FHIR © HL7.org  |  Server Home  |  XIG Home  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

Resources - All Kinds, Realm US

18,284 resources

Type: Text:

By Version

By Authority

 

Start Prev Rows 11000 - 11200 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuth
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.105.11.1062Major Depression In Remissionactive2025-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.105.11.1161Schizophrenia or Psychotic Disorderactive2022-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.105.11.1162Schizophrenia or Psychotic Disorderactive2022-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.105.11.1163Schizophrenia or Psychotic Disorderactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.105.11.1206Mental Behavioral and Neurodevelopmental Disordersactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.105.11.1207Mental Behavioral and Neurodevelopmental Disordersactive2025-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.105.11.1210Schizophreniaactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.105.11.1211Schizophreniaactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.105.11.1212Seizure Disorderactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.105.11.1213Seizure Disorderactive2025-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.105.11.1214REMactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.105.11.1215REMactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.105.11.1216Benzodiazepine Withdrawalactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.105.11.1217Benzodiazepine Withdrawalactive2025-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.105.11.1218Alcohol Withdrawalactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.105.11.1219Alcohol Withdrawalactive2025-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.105.11.1220General Anxietyactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.105.11.1221General Anxietyactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.105.12.1004Mental Health Diagnosesactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.105.12.1007Major Depressionactive2017-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.105.12.1104Schizophrenia or Psychotic Disorderactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.105.12.1203Mental Behavioral and Neurodevelopmental Disordersactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.105.12.1205Schizophreniaactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.105.12.1206Seizure Disorderactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.105.12.1207REM Sleep Behavior Disorderactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.105.12.1208Benzodiazepine Withdrawalactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.105.12.1209Alcohol Withdrawalactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.105.12.1210Generalized Anxiety Disorderactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.1050Potentially Harmful Gastrointestinal Antispasmodics for Older Adultsactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.1051Dipyridamole Medicationsactive2021-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.1053Nifedipine Medicationsactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.1054Potentially Harmful Antidepressants for Older Adultsactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.1055Potentially Harmful Barbiturates for Older Adultsactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.1057Meprobamate Medicationsactive2021-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.1058Potentially Harmful Estrogens for Older Adultsactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.1059Potentially Harmful Sulfonylureas for Older Adultsactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.106.11.1001Substance Use Disorderactive2025-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.106.11.1003Substance Use Disorderactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.106.11.1012Substance Use Disorder Treatmentactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.106.11.1036Substance Use Disorder Treatmentactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.106.12.1001Substance Use Disorderactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.106.12.1005Substance Use Disorder Treatmentactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.1060Desiccated Thyroid Medicationsactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.1062Potentially Harmful Skeletal Muscle Relaxants for Older Adultsactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.1063Potentially Harmful Pain Medications for Older Adultsactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.1065Digoxin Medicationsactive2021-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.1066Digoxin Medicationsactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.1067Doxepin Medicationsactive2021-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.1068Doxepin Medicationsactive2021-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.108.11.1001Malignant Neoplasm of Colonactive2024-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.108.11.1003Malignant Neoplasm of Colonactive2023-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.108.11.1025Malignant Neoplasm of Lymphatic and Hematopoietic Tissueactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.108.11.1027Malignant Neoplasm of Lymphatic and Hematopoietic Tissueactive2022-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.108.11.1044Pap Testactive2017-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.108.11.1047Mammographyactive2024-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.108.11.1051Colonoscopyactive2023-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.108.11.1052Colonoscopyactive2017-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.108.11.1053Colonoscopyactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.108.11.1145sDNA FIT Testactive2017-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.108.12.1001Malignant Neoplasm of Colonactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.108.12.1009Malignant Neoplasm of Lymphatic and Hematopoietic Tissueactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.108.12.1017Pap Testactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.108.12.1018Mammographyactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.108.12.1020Colonoscopyactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.108.12.1038CT Colonographyactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.108.12.1039sDNA FIT Testactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.109.11.1024Kidney Transplantactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.109.11.1025Kidney Transplantactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.109.11.1026Dialysis Servicesactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.109.11.1027Dialysis Servicesactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.109.11.1028Dialysis Servicesactive2017-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.109.11.1029ESRD Monthly Outpatient Servicesactive2017-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.109.11.1052Kidney Transplantactive2017-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.109.11.1060Kidney Transplant Recipientactive2019-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.109.11.1067Kidney Transplantactive2019-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.109.12.1012Kidney Transplantactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.109.12.1013Dialysis Servicesactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.109.12.1014ESRD Monthly Outpatient Servicesactive2017-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.109.12.1029Kidney Transplant Recipientactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1065DTaP Vaccine Administeredactive2021-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1066DTaP Vaccine Administeredactive2024-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1068Hepatitis Aactive2019-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1070Hepatitis Aactive2017-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1078Measlesactive2021-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1080Measlesactive2017-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1085Measles, Mumps and Rubella (MMR) Vaccine Administeredactive2017-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1086Measles, Mumps and Rubella (MMR) Vaccine Administeredactive2023-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1087Mumpsactive2023-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1089Mumpsactive2017-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1098Rubellaactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.110Rubellaactive2017-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1104Varicella Zosteractive2017-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1105Varicella Zosteractive2025-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1106Varicella Zoster Vaccine (VZV) Administeredactive2017-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1107Varicella Zoster Vaccine (VZV) Administeredactive2023-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1109Hepatitis A Vaccine Administeredactive2017-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1110Hepatitis A Vaccine Administeredactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1111Hepatitis B Vaccine Administeredactive2021-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1112Hepatitis B Vaccine Administeredactive2023-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1115Child Influenza Vaccine Administeredactive2023-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1116Child Influenza Vaccine Administeredactive2023-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1117Inactivated Polio Vaccine (IPV) Administeredactive2021-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1118Inactivated Polio Vaccine (IPV) Administeredactive2023-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1119Pneumococcal Conjugate Vaccine Administeredactive2023-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1120Rotavirus Vaccine (3 dose schedule) Administeredactive2017-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1121Rotavirus Vaccine (2 dose schedule) Administeredactive2017-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1123Genital Herpesactive2024-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1124Genital Herpesactive2024-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1128Lab Tests for Sexually Transmitted Infectionsactive2022-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1129Chlamydia Screeningactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1133Pneumococcal Conjugate Vaccine Administeredactive2024-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1135HPV Testactive2024-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1148Rotavirus Vaccine (2 Dose Schedule) Administeredactive2019-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1149Rotavirus Vaccine (3 Dose Schedule) Administeredactive2019-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1150Advanced Illnessactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1151Advanced Illnessactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1152HiB Vaccine (3 dose schedule)active2021-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1153HiB Vaccine (3 dose schedule) Administeredactive2021-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1154HiB Vaccine (4 dose schedule)active2021-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1155HiB Vaccine (4 dose schedule) Administeredactive2021-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1156HiB Vaccine (3 dose schedule) Administeredactive2024-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1157HiB Vaccine (4 dose schedule) Administeredactive2024-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1158Competing Conditions for Respiratory Conditionsactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.11.1159Competing Conditions for Respiratory Conditionsactive2023-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.12.1022DTaP Vaccine Administeredactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.12.1024Hepatitis Aactive2017-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.12.1031Measles, Mumps and Rubella (MMR) Vaccine Administeredactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.12.1032Mumpsactive2017-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.12.1037Rubellaactive2017-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.12.1039Varicella Zosteractive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.12.1040Varicella Zoster Vaccine (VZV) Administeredactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.12.1041Hepatitis A Vaccine Administeredactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.12.1042Hepatitis B Vaccine Administeredactive2022-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.12.1044Child Influenza Vaccine Administeredactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.12.1045Inactivated Polio Vaccine (IPV) Administeredactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.12.1046Pneumococcal Conjugate Vaccine Administeredactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.12.1047Rotavirus Vaccine (3 dose schedule) Administeredactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.12.1048Rotavirus Vaccine (2 dose schedule) Administeredactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.12.1049Genital Herpesactive2018-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.12.1051Lab Tests for Sexually Transmitted Infectionsactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.12.1052Chlamydia Screeningactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.12.1053Measlesactive2017-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.12.1059HPV Testactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.12.1082Advanced Illnessactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.12.1083Hib Vaccine (3 dose schedule)active2019-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.12.1084Hib Vaccine (3 dose schedule) Administeredactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.12.1085Hib Vaccine (4 dose schedule)active2019-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.12.1086Hib Vaccine (4 dose schedule) Administeredactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.12.1087Influenza Virus LAIV Vaccineactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.110.12.1088Influenza Virus LAIV Vaccine Administeredactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.111.11.1012Lab Tests During Pregnancyactive2023-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.111.11.1013Diagnostic Studies During Pregnancyactive2022-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.111.11.1019Pregnancy Testactive2023-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.111.11.1022Complications of Pregnancy, Childbirth and the Puerperiumactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.111.11.1023Complications of Pregnancy, Childbirth and the Puerperiumactive2023-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.111.11.1028Procedures for Sexual Activityactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.111.11.1030Procedures for Sexual Activityactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.111.11.1031Diagnosis for Sexual Activityactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.111.11.1032Diagnosis for Sexual Activityactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.111.11.1033Procedures for Sexual Activityactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.111.12.1007Lab Tests During Pregnancyactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.111.12.1008Diagnostic Studies During Pregnancyactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.111.12.1011Pregnancy Testactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.111.12.1012Complications of Pregnancy, Childbirth and the Puerperiumactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.111.12.1016Congenital or Acquired Absence of Cervixactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.111.12.1017Procedures Used to Indicate Sexual Activityactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.111.12.1018Diagnoses Used to Indicate Sexual Activityactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.112.11.1024Absence of Cervixactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.112.11.1025Absence of Cervixactive2021-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.112.11.1026Absence of Cervixactive2023-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.113.11.1073Osteoporosis Without Current Fractureactive2017-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.113.11.1074Osteoporosis Without Current Fractureactive2023-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.113.11.1200Osteoporosis With Current Fractureactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.113.11.1201Osteoporosis With Current Fractureactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.113.11.1202DXA (Dual energy Xray Absorptiometry) Scan Non Hip or Spineactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.113.11.1308Frailty Diagnosisactive2024-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.113.11.1309Frailty Diagnosisactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.113.11.1310Frailty Symptomactive2023-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.113.11.1311Frailty Symptomactive2023-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.113.12.1038Osteoporosis Without Current Fractureactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.113.12.1050Osteoporosis With Current Fractureactive2018-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.113.12.1051DXA (Dual energy Xray Absorptiometry) Scanactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.113.12.1074Frailty Diagnosisactive2019-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.113.12.1075Frailty Symptomactive2019-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.114.11.1021Narcolepsyactive2018-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.114.11.1023Narcolepsyactive2017-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.114.11.1024Neurologic impairmentactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.114.11.1025Neurologic impairmentactive2017-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.114.11.1026Neurologic impairmentactive2021-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.114.12.1011Narcolepsyactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.114.12.1012Neurologic impairmentactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.1149Substance Use Disorder Long Acting Medicationactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.115.11.1248Retinal or Dilated Eye Examactive2025-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.115.12.1088Retinal or Dilated Eye Examactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.1150Substance Use Disorder Short Acting Medicationactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.1151Substance Use Disorder Long Acting Medication Administrationactive2025-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.1152Substance Use Disorder Short Acting Medication Administrationactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.1155Substance Use Disorder Short Acting Medication Administrationactive2023-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.1156Substance Use Disorder Long Acting Medication Administrationactive2021-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.1157Substance Use Disorder Short Acting Medication Administrationactive2022-03hl7